Showing results (451-460 of 6,286) with videos related to

Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|August 14, 2019
Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetesRobert J Chilton
Diabetes, Obesity & Metabolism|March 30, 2019
Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensusBrian M Frier, Alexandria Ratzki-Leewing, Stewart B Harris
Diabetes, Obesity & Metabolism|March 30, 2019
Low versus high carbohydrate diet in type 1 diabetes: A 12-week randomized open-label crossover studySigne Schmidt, Merete B Christensen, Nermin Serifovski, et al.
Diabetes, Obesity & Metabolism|March 30, 2019
Short-term cost-utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)Richard F Pollock, Simon Heller, Thomas R Pieber, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acidsDaniel J Sansome, Cong Xie, Simon Veedfald, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trialJeroen V Koomen, Hiddo J L Heerspink, Ilse C Schrieks, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Effects of sitagliptin on gastric emptying of, and the glycaemic and blood pressure responses to, a carbohydrate meal in type 2 diabetesJulie E Stevens, Madeline Buttfield, Tongzhi Wu, et al.
Diabetes, Obesity & Metabolism|September 4, 2019
Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study)Young Min Cho, Chaicharn Deerochanawong, Samroeng Seekaew, et al.
Diabetes, Obesity & Metabolism|September 11, 2019
Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study)Soo Heon Kwak, You-Cheol Hwang, Jong Chul Won, et al.
Diabetes, Obesity & Metabolism|September 13, 2019
Efficacy of metformin in preventing progression to diabetes in a Chinese population with impaired glucose regulation: Protocol for a multicentre, open-label, randomized controlled clinical studyLinong Ji, Ningling Sun, Yunliang Zhang, et al.
Pageof 629